Malin Corporation plc (MLC) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.008x

Based on the latest financial reports, Malin Corporation plc (MLC) has a cash flow conversion efficiency ratio of -0.008x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-800.00K ≈ $-935.28K USD) by net assets (€96.20 Million ≈ $112.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Malin Corporation plc's balance sheet to measure how much of total assets are equity-financed.

Malin Corporation plc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Malin Corporation plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Malin Corporation plc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Malin Corporation plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Malin Corporation plc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SCD Co. Ltd
KQ:042110
0.014x
Concraft Holding Co Ltd
TW:4943
0.011x
Sunndal Sparebank
OL:SUNSB
N/A
Creative Realities Inc
NASDAQ:CREX
-0.042x
Willowglen MSC Bhd
KLSE:0008
0.021x
Hipay Group SA
PA:ALHYP
0.086x
Aarti Surfactants Limited
NSE:AARTISURF
0.091x
Abocom Systems Inc
TW:2444
-0.115x

Annual Cash Flow Conversion Efficiency for Malin Corporation plc (2015–2024)

The table below shows the annual cash flow conversion efficiency of Malin Corporation plc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Malin Corporation plc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €193.20 Million
≈ $225.87 Million
€-1.30 Million
≈ $-1.52 Million
-0.007x +76.97%
2023-12-31 €109.50 Million
≈ $128.02 Million
€-3.20 Million
≈ $-3.74 Million
-0.029x -14.91%
2022-12-31 €283.10 Million
≈ $330.97 Million
€-7.20 Million
≈ $-8.42 Million
-0.025x -21.03%
2021-12-31 €218.90 Million
≈ $255.92 Million
€-4.60 Million
≈ $-5.38 Million
-0.021x -103.21%
2020-12-31 €290.10 Million
≈ $339.16 Million
€-3.00 Million
≈ $-3.51 Million
-0.010x +54.83%
2019-12-31 €179.10 Million
≈ $209.39 Million
€-4.10 Million
≈ $-4.79 Million
-0.023x +70.89%
2018-12-31 €170.40 Million
≈ $199.22 Million
€-13.40 Million
≈ $-15.67 Million
-0.079x +35.99%
2017-12-31 €221.40 Million
≈ $258.84 Million
€-27.20 Million
≈ $-31.80 Million
-0.123x -68.98%
2016-12-31 €308.10 Million
≈ $360.20 Million
€-22.40 Million
≈ $-26.19 Million
-0.073x -56.27%
2015-12-31 €365.40 Million
≈ $427.19 Million
€-17.00 Million
≈ $-19.87 Million
-0.047x --

About Malin Corporation plc

IR:MLC Ireland Drug Manufacturers - Specialty & Generic
Market Cap
$35.91 Million
€30.72 Million EUR
Market Cap Rank
#23105 Global
#20 in Ireland
Share Price
€7.10
Change (1 day)
-1.39%
52-Week Range
€7.00 - €8.65
All Time High
€15.37
About

Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It also engages in investment activities. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.